查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1472035

骨盆腔器官脫垂修復的全球市場 - 全球產業分析、規模、份額、成長、趨勢、區域展望、預測（2024-2031）

Pelvic Organ Prolapse Repair Market - Global Pelvic Organ Prolapse Repair Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 -
出版日期: | 出版商: Fairfield Market Research | 英文 202 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球骨盆器官脫垂 (POP) 修復市場規模預計將從 2024 年的 4.2 億美元增至 2031 年的 6 億美元。 預計 2024 年至 2031 年期間，市場將以 5.23% 的複合年增長率擴張。

市場擴張是由幾個關鍵因素推動的。 首先，世界人口老化，加上生育和荷爾蒙變化等因素，正在增加骨盆腔器官脫垂的盛行率。 隨著人口結構的不斷發展，恢復性手術的需求也預計將隨之激增。

其次，手術技術和醫療設備的顯著進步徹底改變了骨盆器官脫垂修復的面貌。 與傳統開放式手術相比，微創手術（包括腹腔鏡手術和機器人輔助手術）的創新可縮短恢復時間、降低併發症發生率並提高患者滿意度。

此外，人們對骨盆底疾病認識的提高和治療選擇的增加也增加了患者就骨盆器官脫垂尋求醫療幫助的意願。 醫療保健教育工作、宣傳工作和改善醫療保健服務的可近性進一步促進了早期診斷和治療，推動了市場成長。

本報告調查了全球骨盆器官脫垂修復市場，並概述了市場、治療趨勢、應用、最終用戶、地區以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第2章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • 杵分析

第3章2019-2031年全球骨盆腔器官脫垂修復市場前景

  • 2019-2031 年全球骨盆腔器官脫垂修復市場前景（依治療方法分類）、價值（十億美元）
  • 2019-2031 年全球骨盆器官脫垂修復市場前景（按應用分類）、價值（十億美元）
  • 2019-2031 年全球骨盆器官脫垂修復市場展望，按最終用戶劃分，價值（十億美元）
  • 2019-2031 年全球骨盆腔器官脫垂修復市場展望（按地區、價值（十億美元））

第4章2019-2031年北美骨盆腔器官脫垂修復市場展望

第5章歐洲骨盆器官脫垂修復市場展望，2019-2031

第6章亞太盆腔器官脫垂修復市場展望，2019-2031

第7章拉丁美洲骨盆腔器官脫垂修復市場展望，2019-2031

第8章中東與非洲骨盆器官脫垂修復市場展望，2019-2031

第9章競爭態勢

  • 按製造商和應用程式劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • Johnson & Johnson Services, Inc.
    • Coloplast A/S
    • Dipromed Srl
    • Boston Scientific Corporation
    • PFM medical ag
    • Promedon Group
    • Caldera Medical
    • Cook Medical
    • Medgyn Products, Inc.
    • Cooper Surgical, Inc.
    • DIMA S.L.
    • Digitimer Ltd.
    • Bray Group Ltd.
    • Medesign Ingenieur-Consulting GmbH
    • Panpac Medical Corp.

第10章 附錄

簡介目錄

Global pelvic organ prolapse (POP) repair market is on track for substantial growth, with projections indicating a valuation of US$600 million by 2031, soaring from US$420 million in 2024. This impressive expansion is anticipated to occur at a compound annual growth rate (CAGR) of 5.23% during the period spanning 2024 to 2031.

Key Growth Drivers

The market's upward trajectory is fueled by several pivotal factors. Firstly, the ageing Global population, combined with occurrences such as childbirth and hormonal changes, contribute to a heightened prevalence of pelvic organ prolapse. As demographics continue to evolve, the demand for repair procedures is expected to surge accordingly.

Secondly, significant advancements in surgical techniques and medical devices have transformed the landscape of pelvic organ prolapse repair. Innovations in minimally invasive procedures, including laparoscopic and robotic-assisted surgeries, have led to reduced recovery times, lower complication rates, and enhanced patient satisfaction compared to traditional open surgeries.

Moreover, increased awareness of pelvic floor disorders and the availability of treatment options have spurred greater patient willingness to seek medical assistance for pelvic organ prolapse. Healthcare education initiatives, advocacy efforts, and improved access to healthcare services further facilitate early diagnosis and treatment, thus propelling market growth.

Major Growth Barriers

Despite the promising outlook, the market faces notable challenges. Safety concerns surrounding certain surgical techniques and devices, particularly mesh implants, have prompted heightened regulatory scrutiny and stricter approval processes. Legal challenges stemming from product liability claims also pose hurdles to market expansion, contributing to uncertainty and potentially deterring investment in research and development.

Additionally, the emergence of alternative treatment modalities, such as pelvic floor physical therapy and lifestyle modifications, presents a restraint to market growth. Some patients may prefer conservative management approaches over surgical interventions, impacting adoption rates for pelvic organ prolapse repair procedures.

Key Trends and Opportunities

Several trends and opportunities shape the future trajectory of the pelvic organ prolapse repair market. Notably, there is a significant shift towards minimally invasive procedures, driven by associated benefits such as shorter hospital stays, faster recovery times, and reduced post-operative pain.

Furthermore, there is a growing interest in biologic and tissue-engineered implants as alternatives to synthetic mesh materials. These implants offer the potential for improved integration with host tissues and reduced risk of complications, driving research and development activity in this area.

Moreover, the development of patient-specific treatment approaches presents a significant opportunity for market players to enhance treatment outcomes and gain a competitive edge. Personalized medicine approaches, tailored to individual patient characteristics, have the potential to improve clinical outcomes and patient satisfaction.

Expansion into emerging markets, particularly in regions such as Asia-Pacific, Latin America, and the Middle East, also offers significant growth potential. Rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness of pelvic floor disorders contribute to the fertile ground for market expansion in these regions.

Regional Frontrunners

Currently, North America leads the pelvic organ prolapse repair market, owing to factors such as a higher prevalence of POP, robust healthcare infrastructure, and the presence of established industry players. Europe follows closely, with a strong presence of Global industry leaders and rising awareness of pelvic floor disorders.

The Asia Pacific region is emerging as a significant player in the market, fueled by increasing awareness, a large and ageing female population, and expanding healthcare infrastructure. Medical tourism further accelerates market growth in this region.

Leaders in Global Pelvic Organ Prolapse Repair Space

Key players driving innovation and growth in the pelvic organ prolapse repair market include:

Johnson & Johnson Services, Inc.

Coloplast A/S

Dipromed Srl

Boston Scientific Corporation (American Medical Systems Inc.)

pfm medical ag

Betatech Medical

Promedon Group

Caldera Medical

Cook Medical

MEDGYN PRODUCTS, INC.

CooperSurgical, Inc.

DIMA S.L.

Digitimer Ltd

Bray Group Ltd,

medesign Ingenieur-Consulting GmbH

Panpac Medical Corp.

for.me.sa.

Bioteque America Inc.

Bliss GVS Pharma

Panpac Medical Corporation

Personal Medical Corporation

Dr. Arabin GmbH & Co.

Kangge Medical

Integra Lifesciences

Wallach Surgical Devices

Medesign

Market Segmentation

The Global Pelvic Organ Prolapse Repair Market is segmented as follows:

By Treatment:

Non-surgical:

Pessary

Pelvic Floor Muscle Therapy

Surgical:

Colpocleisis

Colporrhaphy

Sacrocolpopexy

Sacrohysteropexy

Uterosacral or Sacrospinous Ligament Fixation

By Application:

Cystocele

Urethrocele

Enterocele

Uterine Prolapse

Posterior Vaginal Wall Prolapse (dropped rectum)

By End User:

Hospitals

Specialized Clinics

Female Care Facilities

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 3.1. Global Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Non-surgical
        • 3.1.1.1.1. Pessary
        • 3.1.1.1.2. Pelvic Floor Muscle Therapy
      • 3.1.1.2. Surgical
        • 3.1.1.2.1. Colpocleisis
        • 3.1.1.2.2. Colporrhaphy
        • 3.1.1.2.3. Sacrocolpopexy
        • 3.1.1.2.4. Sacrohysteropexy
        • 3.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 3.2. Global Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cystocele
      • 3.2.1.2. Urethrocele
      • 3.2.1.3. Enterocele
      • 3.2.1.4. Uterine Prolapse
      • 3.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 3.3. Global Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialized Clinics
      • 3.3.1.3. Female Care Facilities
  • 3.4. Global Pelvic Organ Prolapse Repair Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 4.1. North America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. By Treatment
        • 4.1.1.1.1. Pessary
        • 4.1.1.1.2. Pelvic Floor Muscle Therapy
      • 4.1.1.2. Surgical
        • 4.1.1.2.1. Colpocleisis
        • 4.1.1.2.2. Colporrhaphy
        • 4.1.1.2.3. Sacrocolpopexy
        • 4.1.1.2.4. Sacrohysteropexy
        • 4.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 4.2. North America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cystocele
      • 4.2.1.2. Urethrocele
      • 4.2.1.3. Enterocele
      • 4.2.1.4. Uterine Prolapse
      • 4.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 4.3. North America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialized Clinics
      • 4.3.1.3. Female Care Facilities
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 4.4.1.2. U.S. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 4.4.1.3. U.S. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 4.4.1.4. Canada Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 4.4.1.5. Canada Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 4.4.1.6. Canada Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 5.1. Europe Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. By Treatment
        • 5.1.1.1.1. Pessary
        • 5.1.1.1.2. Pelvic Floor Muscle Therapy
      • 5.1.1.2. Surgical
        • 5.1.1.2.1. Colpocleisis
        • 5.1.1.2.2. Colporrhaphy
        • 5.1.1.2.3. Sacrocolpopexy
        • 5.1.1.2.4. Sacrohysteropexy
        • 5.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 5.2. Europe Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cystocele
      • 5.2.1.2. Urethrocele
      • 5.2.1.3. Enterocele
      • 5.2.1.4. Uterine Prolapse
      • 5.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 5.3. Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialized Clinics
      • 5.3.1.3. Female Care Facilities
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Pelvic Organ Prolapse Repair Market By Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.2. Germany Pelvic Organ Prolapse Repair Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.3. Germany Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.4. U.K. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.5. U.K. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.6. U.K. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.7. France Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.8. France Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.9. France Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.10. Italy Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.11. Italy Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.12. Italy Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.13. Turkey Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.14. Turkey Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.15. Turkey Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.16. Russia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.17. Russia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.18. Russia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.19. Rest of Europe Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.20. Rest of Europe Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.21. Rest of Europe Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. By Treatment
        • 6.1.1.1.1. Pessary
        • 6.1.1.1.2. Pelvic Floor Muscle Therapy
      • 6.1.1.2. Surgical
        • 6.1.1.2.1. Colpocleisis
        • 6.1.1.2.2. Colporrhaphy
        • 6.1.1.2.3. Sacrocolpopexy
        • 6.1.1.2.4. Sacrohysteropexy
        • 6.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 6.2. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cystocele
      • 6.2.1.2. Urethrocele
      • 6.2.1.3. Enterocele
      • 6.2.1.4. Uterine Prolapse
      • 6.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 6.3. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialized Clinics
      • 6.3.1.3. Female Care Facilities
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.2. China Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.3. China Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.4. Japan Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.5. Japan Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.6. Japan Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.7. South Korea Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.8. South Korea Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.9. South Korea Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.10. India Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.11. India Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.12. India Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.13. Southeast Asia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.14. Southeast Asia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.15. Southeast Asia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.16. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.17. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.18. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 7.1. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. By Treatment
        • 7.1.1.1.1. Pessary
        • 7.1.1.1.2. Pelvic Floor Muscle Therapy
      • 7.1.1.2. Surgical
        • 7.1.1.2.1. Colpocleisis
        • 7.1.1.2.2. Colporrhaphy
        • 7.1.1.2.3. Sacrocolpopexy
        • 7.1.1.2.4. Sacrohysteropexy
  • 7.2. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Cystocele
      • 7.2.1.2. Urethrocele
      • 7.2.1.3. Enterocele
      • 7.2.1.4. Uterine Prolapse
      • 7.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 7.3. Latin America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialized Clinics
      • 7.3.1.3. Female Care Facilities
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.2. Brazil Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.3. Brazil Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.4. Mexico Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.5. Mexico Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.6. Mexico Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.7. Argentina Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.8. Argentina Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.9. Argentina Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.10. Rest of Latin America Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.11. Rest of Latin America Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.12. Rest of Latin America Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. By Treatment
        • 8.1.1.1.1. Pessary
        • 8.1.1.1.2. Pelvic Floor Muscle Therapy
      • 8.1.1.2. Surgical
        • 8.1.1.2.1. Colpocleisis
        • 8.1.1.2.2. Colporrhaphy
        • 8.1.1.2.3. Sacrocolpopexy
        • 8.1.1.2.4. Sacrohysteropexy
        • 8.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 8.2. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cystocele
      • 8.2.1.2. Urethrocele
      • 8.2.1.3. Enterocele
      • 8.2.1.4. Uterine Prolapse
      • 8.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 8.3. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialized Clinics
      • 8.3.1.3. Female Care Facilities
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.2. GCC Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.3. GCC Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.4. South Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.5. South Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.6. South Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.7. Egypt Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.8. Egypt Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.9. Egypt Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.10. Nigeria Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.11. Nigeria Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.12. Nigeria Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Johnson & Johnson Services, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Coloplast A/S
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Dipromed Srl
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Boston Scientific Corporation (American Medical Systems Inc.)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. PFM medical ag
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Promedon Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Caldera Medical
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Cook Medical
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Medgyn Products, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Cooper Surgical, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. DIMA S.L.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Digitimer Ltd.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Bray Group Ltd.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Medesign Ingenieur-Consulting GmbH
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Panpac Medical Corp.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations